SEC FORM 4
$38,675.00
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
Sale of 8,750 shares at $4.42 per share.
Reporting Person Reynoso Jamie L. · Officer Title CEO, Medicare Advantage · Transaction Code S
Traded Oct 5, 2026 · Disclosed Oct 5, 2026
Source: SEC Form 4 · 0001839066-26-000052 · filed 2026-10-05 · View filing →